Company: RNAC
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001453687-25-000060
Chunk: 5

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 5
---
-K001-377983.16/29/20163.1(b)Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated June 21, 20228-K001-377983.16/21/20223.1(c)Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated November 13, 20238-K001-377983.311/13/20233.1(d)Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Cartesian Therapeutics, Inc., dated March 28, 2024.8-K001-377983.23/28/20243.2Amended and Restated By-laws of Cartesian Therapeutics, Inc.10-Q001-377983.211/13/20234.1Specimen Stock Certificate evidencing the shares of common stock———Filed herewith4.2Form of Warrant to Purchase Shares of Series E Preferred Stock, dated December 31, 2015, issued by the Registrant to Oxford Finance LLC and Square One Bank, together with a schedule of warrant holdersS-1333-2115554.65/24/20164.3Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ)10-Q001-377984.18/6/20204.4Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ), as amended on November 4, 202010-Q001-377984.211/5/20204.5Form of Warrant to Purchase Stock, dated August 31, 2020, issued by Selecta Biosciences, Inc. to Oxford Finance LLC and Silicon Valley Bank, together with a schedule of warrants.8-K001-377984.19/3/20204.6Form of Common Stock Purchase Warrant, dated April 11, 20228-K001-377984.14/6/20224.7Form of Contingent Value Rights Agreement8-K001-377982.111/13/20234.8Registration Rights Agreement, by and among Selecta Biosciences, Inc. and certain purchasers party thereto8-K001-3779810.211/13/20234.9